Macrophage migration inhibitory factor in the immune response

References

• Benjamin CF, Hogaboam CM, Kunkel SL. The chronic consequences of severe sepsis. J Leukoc Biol 2004; 75: 408–12
   Google Scholar
• Quartin AA, Schein RM, Kett DH, Peduzzi P. Magnitude and duration of the effect of sepsis on survival: Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997; 277: 1058–63
   PubMed Web of Science ®Google Scholar
• Bloom BR, Bennet B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153: 80–2
   PubMed Web of Science ®Google Scholar
• David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 1966; 56: 72–7
   PubMed Web of Science ®Google Scholar
• Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, David JR. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 1989; 86: 7522–6
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756–9
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994; 33: 14144–55
   PubMed Web of Science ®Google Scholar
• Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R. Cloning and characterization of the gene for mouse macrophage inhibitory factor (MIF). J Immunol 1995; 154: 3863–70
   PubMed Web of Science ®Google Scholar
• Sun HW, Bernhagen J, Bucala R, Lolis E. Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A 1996; 93: 5191–6
   PubMed Web of Science ®Google Scholar
• Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microb Infect 2002; 4: 449–60
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791–800
   PubMed Web of Science ®Google Scholar
• Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R, et al. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci U S A 2003; 100: 9354–9
   PubMed Web of Science ®Google Scholar
• Bacher M, Meinhardt A, Lan HY, Dhabhar FS, Wu M, Metz CN, et al. MIF expression in the rat brain: implications for neuronal function. Mol Med 1998; 4: 217–30
   PubMed Web of Science ®Google Scholar
• Nishio Y, Minami A, Kato H, Kaneda K, Nishihira J. Identification of macrophage migration inhibitory factor (MIF) in rat peripheral nerves: its possible involvement in nerve regeneration. Biochem Biophys Acta 1999; 1453: 74–82
   PubMed Web of Science ®Google Scholar
• Fingerle-Rowson G, Koch P, Bikoff R, Lin X, Metz CN, Dhabhar FS, et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003; 162: 47–56
   PubMed Web of Science ®Google Scholar
• Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467–76
   PubMed Web of Science ®Google Scholar
• Santos LL, Lacey D, Yang Y, Leech M, Morand EF. Activation of synovial p38 MAP kinase by macrophage migration inhibitory factor. J Rheumatol 2004; 31: 1038–43
   PubMedGoogle Scholar
• Kudrin A, Scott M, Martin S, Chung C, Donn R, McMaster A, et al. Human macrophage migration inhibitory factor. A proven immunomodulatory cytokine?. J Biol Chem 2006; 281: 29641–51
   Google Scholar
• Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68–71
   PubMed Web of Science ®Google Scholar
• Roger T, Chanson AL, Knaup-Reymond M, Calandra T. Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1. Eur J Immunol 2005; 35: 3405–13
   PubMed Web of Science ®Google Scholar
• Aeberli D, Yang Y, Mansell A, Santos L, Leech M, Morand EF. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett 2006; 580: 974–81
   PubMed Web of Science ®Google Scholar
• Aeberli D, Leech M, Morand EF. Macrophage migration inhibitory factor and glucocorticoid sensitivity. Rheumatology 2006; 45: 937–43
   PubMedGoogle Scholar
• Abraham SM, Lawrence T, Kleinman A, Warden P, Medghalchi M, Tuckermann J, et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual-specificity phosphatase-1. J Exp Med 2006; 203: 1883–9
   PubMed Web of Science ®Google Scholar
• Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato ACB, et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 2006; 203: 15–20
   PubMedGoogle Scholar
• Kotlyarov A, Neininger A, Schubert C, Eckert R, Birchmeier C, Volk HD, et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol 1999; 1: 94–7
   PubMed Web of Science ®Google Scholar
• Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hültner L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164–70
   PubMed Web of Science ®Google Scholar
• Larson DF, Horak K. Macrophage migration inhibitory factor: controller of systemic inflammation. Crit Care 2006; 10: 138–10
   PubMed Web of Science ®Google Scholar
• Cvetkovic I, Stosic-Grujicic S. Neutralization of macrophage migration inhibitory factor—novel approach for the treatment of immunoinflammatory disorders. Int Immunopharmacol 2006; 6: 1527–34
   PubMed Web of Science ®Google Scholar
• Morand EF. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Intern Med J 2005; 35: 419–26
   PubMed Web of Science ®Google Scholar
• Bozza FA, Gomes RN, Japiassu AM, Soares M, Castro-Faria-Neto HC, Bozza PT, et al. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 2004; 22: 309–13
   PubMed Web of Science ®Google Scholar
• Gregory JL, Leech MT, David JR, Yang YH, Dacumos A, Hickey MJ. Reduced leukocyte-endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. Arthritis Rheum 2004; 50: 3023–34
   Google Scholar
• Denkinger CM, Metz C, Fingerle-Rowson G, Denkinger MD, Forsthuber T. Macrophage migration inhibitory factor and its role in autoimmune diseases. Arch Immunol Ther Exp 2004; 52: 389–400
   Google Scholar
• Rogge L. A genomic view of helper T cell subsets. Ann N Y Acad Sci 2002; 975: 57–67
   Google Scholar
• Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 2002; 168: 2493–500
   PubMed Web of Science ®Google Scholar
• Ding Y, Chung C-S, Newton S, Chen Y, Carlton S, Albina JE, et al. Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock 2004; 22: 137–44
   PubMed Web of Science ®Google Scholar
• Efron PA, Martins A, Minnich D, Tinsley K, Ungaro R, Bahjat FR, et al. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol 2004; 173: 3035–43
   PubMed Web of Science ®Google Scholar
• Flohé SB, Agrawal H, Schmitz D, Gertz M, Flohé S, Schade FU. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response. J Leukoc Biol 2006; 79: 473–81
   PubMed Web of Science ®Google Scholar
• Scumbia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, McAuliffe P, et al. Increased natural CD4 + CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 2006; 177: 7943–9
   Google Scholar
• Chen X, Bäumel M, Männel DN, Howard OMZ, Oppenheim JJ. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 2007; In press.
   Google Scholar
• Van der Sluis K, Nijhuis M, Levels JHM, Florquin S, Mellor AL, Jansen HM, et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances Interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 2006; 193: 214–22
   Google Scholar
• Benjamin CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 2005; 105: 3588–95
   PubMedGoogle Scholar
• Pollak N, Sterns T, Echtenacher B, Männel DN. Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor. Infect Immun 2005; 73: 6488–92
   PubMedGoogle Scholar
• Echtenacher B, Urbaschek R, Weigl K, Freudenberg MA, Männel DN. Treatment of experimental sepsis-induced immunoparalysis with TNF. Immunobiology 2003; 208: 381–9
   Google Scholar